Ex­clu­sive: PhRMA at­tacks fed­er­al gov­ern­men­t's re­sponse to re­bate mod­el for 340B

The phar­ma in­dus­try’s DC-based lob­by­ing group urged the fed­er­al gov­ern­ment on Fri­day to get on board with al­ter­na­tive mod­els for 340B drug price dis­counts. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER